Table 2. Overall response to treatment and outcome.
| No. of patients | |
|---|---|
| Response to primary chemotherapy | n=65 |
| Complete response | 16 (24%) |
| Partial response | 41 (62%) |
| Overall response rate | 57 (86%) |
| No change | 6 (9%) |
| Progressive disease | 2 (3%) |
| Surgery | n=66 |
| Conservative | 36 (55%) |
| Mastectomy | 17 (26%) |
| No surgery | 13 (19%) |
| Pathological status at surgery | n=66 |
| Residual invasive disease | 46 (70%) |
| Complete pathological response | 5 (7.5%) |
| DCIS only | 3 (4.5%) |
| Overall progression-free survival | n=66 |
| 1 year | 87% |
| 2 years | 74% |
| 3 years | 65% |
| Overall survival | n=66 |
| 1 year | 93% |
| 2 years | 83% |
| 3 years | 77% |
DCIS=ductal carcinoma in situ.